Sana Kliniken AG

Comments on the guidelines (2018) of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH) on themanagement of arterial hypertension (2019) Mahfoud F, Boehm M, Bongarth CM, Bosch R, Schmieder R, Schunkert H, Stellbrink C, et al. Journal article, Editorial Abhängigkeit eines indikationsspezifischen Algorithmus zur Schritterkennung bei Personen mit Multipler Sklerose von Gehgeschwindigkeit und Trageposition (2019) Shammas L, Rashid A, Tallner A, Hartung V, Streber R, Wanner P, Roth B, et al. Conference contribution, Abstract of a poster Treatment of Early Breast Cancer Patients: Evidence, Controversies, Consensus: Focusing on Systemic Therapy - German Experts' Opinions for the 16th International St. Gallen Consensus Conference (Vienna 2019) (2019) Lüftner D, Bauerfeind I, Braun M, Brucker SY, Fasching P, Felberbaum R, Hagemann F, et al. Journal article MRI-Based Use of Neoadjuvant Chemoradiotherapy in Rectal Carcinoma: Surgical Quality and Histopathological Outcome of the OCUM Trial (2019) Kreis ME, Ruppert R, Kube R, Strassburg J, Lewin A, Baral J, Maurer CA, et al. Journal article AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2019 (2019) Thill M, Jackisch C, Janni W, Müller V, Albert US, Bauerfeind I, Blohmer J, et al. Journal article AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019 (2019) Ditsch N, Untch M, Thill M, Müller V, Janni W, Albert US, Bauerfeind I, et al. Journal article Primary Therapy of Early Breast Cancer: Evidence, Controversies, Consensus (2019) Untch M, Thomssen C, Bauerfeind I, Braun M, Brucker SY, Felberbaum R, Hagemann F, et al. Journal article Real-world effectiveness of ribociclib 1 aromatase inhibitor, or endocrine monotherapy, or chemotherapy as first-line treatment in postmenopausal women with HR-positive, HER2-negative locally advanced or metastatic breast cancer: The RIBANNA study (2018) Fasching P, Decker T, Guderian G, Heim J, Jackisch C, Lueck HJ, Lueftner D, et al. Conference contribution Mutational diversity and therapy response in breast cancer-a sequencing analysis in the neoadjuvant GeparSepto trial (2018) Loibl S, Treue D, Budczies J, Weber K, Stenzinger A, Schmitt WD, Weichert W, et al. Conference contribution Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients (2018) Roellig C, Kramer M, Gabrecht M, Haenel MH, Herbst R, Kaiser U, Schmitz N, et al. Journal article